Zafin Launches AIOS, an End-to-End Platform to Orchestrate and Govern Agentic Work

23 Jun 2026, 12:15 pm

Jardins d’Arménie at the Monte-Carlo Television Festival: A Story of Heritage, Told Globally

23 Jun 2026, 12:05 pm

Youlife Partners with Thingo Technology to Provide AI-powered Workforce Solutions Across China

23 Jun 2026, 12:00 pm

BedStory® Launches BEDSTORY SPINEALIGN® and Cooling Collection Sleep Systems as Demand Grows for Precision-Tuned Support and Cooler Sleep

23 Jun 2026, 12:00 pm

JMGO Unveils Its Biggest Prime Day Savings Yet on N1S 4K and N3 Ultimate

23 Jun 2026, 12:00 pm

Versework, Asia’s Largest Roblox Studio, Enters Official Roblox Incubator and Raises $2.7M from Altos Ventures

23 Jun 2026, 12:00 pm

TACO BELL® LAUNCHES L.O.C.O.S., ITS FIRST EMOTIONAL SUPPORT TACO PLATFORM FOR FANS IN THEIR FEELS

23 Jun 2026, 12:00 pm

Bybit Expands SpaceX Exposure with $20 SpaceX-Themed Airdrop Welcome Gift and Multiple Trading Instruments

23 Jun 2026, 11:56 am

Democratizing 3D-to-AI Production: Reallusion Debuts iClone Personal and Officially Launches AI Studio

23 Jun 2026, 11:54 am

2026 Hong Kong International Nature-based Solutions Action Week Convened Leaders to Advance High-Integrity NbS From Policy to Projects

23 Jun 2026, 11:12 am

ChinaAMC and KB Asset Management Sign Strategic MOU to Deepen Cross-Border Collaboration

23 Jun 2026, 11:01 am

Iridium’s Next‑Generation Hybrid IoT Module and Development Kit are Now Commercially Available

23 Jun 2026, 11:01 am

Empowering Agentic AI and Sustainable HPC: MiTAC Computing Showcases Agentic AI Infrastructure at ISC 2026

23 Jun 2026, 11:00 am

e-STORAGE and Axpo Partner on First Joint Battery Project in Italy

23 Jun 2026, 11:00 am

Fair Play Menarini International Award

23 Jun 2026, 10:29 am

AutoFull Powers IEM Cologne Major 2026 with World-First Massage Gaming Chairs Featuring Cooling & Heating Seat

23 Jun 2026, 10:11 am

New global estimates reveal 258 million children affected by crises as learning losses threaten an entire generation

23 Jun 2026, 10:10 am

Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

23 Jun 2026, 10:10 am